$heff's $tation of $tocks & $olid DD

[pmony5]

MSTX hmm late stage phase 3 drug trading below cash on hand

As of December 31, 2012, the Company had cash, cash equivalents and short-term investments totaling $36.5 million. Stockholders' equity amounted to $41.8 million as of December 31, 2012. The Company's contingent asset related to the consideration for the acquisition of SynthRx in April 2011 was settled in December 2012. The Company recorded the fair value of the contingent asset as of the settlement date as an adjustment to equity and recognized as a transaction-related expense the increase in its fair value as of its settlement date relative to December 31, 2011 Re: Orphan status granted plus trading for less then CASH on hand Re: European ...